...home of the St. Johns Medical College Community

  • Increase font size
  • Default font size
  • Decrease font size

Painting By Dr Danny George

E-mail Print PDF

Santorini - Acrylic on Canvas.

For me this is about keeping my word. I did rekindle an old habit at the turn of New Year this year. Now, 6 months and 2 exams later, I finally managed to finish this painting. 

Santorini is an island off the mainland of Greece. This picture is iconic. I set about doing this painting because of its striking colours - brilliant blue and white. I thought it would be simple, just blue and white, right? But it became an arduous task trying to get all 50 shades of white correct! Then came a moment when the technique crystallized and from then on, it was rather smooth sailing. Added a few details for the roving eye to pick up.

And thus was completed my first painting in 8 years! 


High Mast Floodlights dedicated by Director

E-mail Print PDF

Father Paul Parathazham, Director of the St John’s National Academy of Health Sciences dedicated the high mast floodlights installed on the Sarjapur Road in front of St John’s Hospital on Monday evening in presence of residents, representatives of various RWAs in Koramangala and adjoining areas as well as officials from the BBMP Streetlight wing. Later sweets were distributed.
Similarly the newly installed floodlights were switched on by former Block Congress President Narayana Gowda at the Beauty Spot Park in Koramangala 5th Block.
Koramangala Ward President Govardhan Reddy, Congress leaders Radhakrishna, Ashok Reddy, Raghuram Reddy, Koramangala 4th Block RWA President G M Shetty, Secretary Cherian, Ejipura New Extension Residents’ Association (ENERA) President Ravindra Kumar, Koramangala 3rd Block RWA Secretary Reggie Thomas, Nitin Seshadri, Dr Umeshwara from 5th Block, Narayana Gowda, Venkatesh Jetty, Kishan Naik, Krishna, from Jakkasandra Extension, Murugesh from 7th Block, BBMP official Sandeep, Kudremukh Colony residents and others were present


Dr Paul Thuluvath's New Book

E-mail Print PDF

Hepatitis C A Complete Guide for Patients and Families


The liver is the body’s workhorse. It makes proteins and bile, processes fats, and detoxifies drugs and alcohol. The liver is a resilient organ, but it is susceptible to damage from a number of sources, including viral infections. Such infections cause inflammation of the liver, called hepatitis. This book is a comprehensive guide to hepatitis C, which affects about 3 percent of the world’s population—3 to 4 million people in the United States alone. Some people with acute hepatitis C infection will be cured without any treatment, but when hepatitis C becomes chronic it may cause cirrhosis, liver cancer, and death.

Hepatitis C is transmitted from an infected person to an uninfected person by sharing drug-injecting equipment, snorting cocaine, having sex, or getting a blood transfusion or organ transplant. It can be spread by getting a tattoo with unsterile equipment. In rare cases, women with hepatitis C transmit the virus to their infants.

World-renowned gastroenterologist and liver specialist Dr. Paul J. Thuluvath provides detailed information about the disease and its diagnosis and management, including dramatically improved treatments that have recently emerged. Dr. Thuluvath answers common and uncommon questions about hepatitis C and liver disease, including

· How is hepatitis C spread? · Who should be tested—and what tests diagnose hepatitis C and other liver diseases? · What are the symptoms of acute liver disease? · What are the symptoms and complications of chronic liver disease? · What are the complications of cirrhosis (scarring of the liver)? · How does hepatitis C affect other organs in the body? · What treatment options are available, and what side effects might they have? · How is early liver cancer diagnosed and treated?· When is liver transplantation needed, and how does it work?

Dr. Thuluvath provides the latest information on new interferon-free regimens, which have shown a cure rate of more than 90% in people with specific genotypes—and which avoid the distressing side effects of interferon therapy. He discusses hepatitis C in children as well as complementary and alternative medicine. Published while revolutionary changes are taking place in the treatment of hepatitis C, this authoritative guide will become the preferred reference for people with hepatitis C and their families.


Paul J. Thuluvath, MD, FRCP, is a professor of medicine and surgery at the University of Maryland School of Medicine and the director of the Institute of Digestive Health and Liver Disease at Mercy Medical Center in Baltimore.

"Superior to similar guides. Incredibly thorough and well-written, the book provides novel information for patients and providers alike."

"A highly readable, up-to-date and comprehensive book for people who have Hepatitis C. Dr. Thuluvath superbly explains this common and often poorly understood condition in an invaluable resource for patients and families in understanding Hepatitis C and its complications and management."


Dr. Anthony Pais delivers Alfred Mascarhenhas Memorial Oration

E-mail Print PDF
Dr Anthony V Pais, professor and head of the department of Surgery (Academic Affairs) and senior consultant surgical oncology, Mazumdar Shaw Cancer Center, Narayana Hrudayalaya Hospital, Bangalore was honored by the department of Surgery, St John’s Medical College, Bangalore with the prestigious Professor Alfred Mascarenhas Oration on June 19. 

On the occasion, Dr Pais spoke on ‘A Century of Technical Evolution in Breast Cancer Surgery’. 

Prof Alfred Mascarenhas served this institution in many capacities continuously and with dedication for 29 years. He was the head of the department of Surgery, Medical Superintendent of St John’s Medical College Hospital and the principal of St John’s Medical College when he retired in 1995. Thereafter he continued to be the Emeritus professor of Surgery. 

He taught and trained many medical students from 1966 till he retired. He was instrumental in starting the postgraduate masters degree (MS) course in General Surgery in this institution in 1982 and many young surgeons who trained under him now occupy senior positions in several prestigious institutions in India and abroad. 

When he passed away, we lost a good friend and a great teacher, mentor and administrator. The Department of Surgery established this oration in his memory in 2002 and since then it has been conducted as a part of our annual Continuing Surgical Education Programme (CSEP) in May–June. 

The department of Surgery selects one eminent surgeon from the country or abroad every year. He /she should have contributed immensely to the field of surgery academically and the community. We have had the honor of having many eminent surgeons deliver this oration including past presidents of the Association of Surgeons of India. 

List of orators is as follows: Dr ArunB Kilpadi (2002), Dr Lucito D’Souza (2003), Dr Ashely D Cruz (2004), Dr Philip Thomas (2005), Dr H Ramesh (2006), Dr C Palanivelu (2007), Dr Ananthakrishnan(2008), Dr Srimurthy (2009), Dr Krishna Rau MS (2010), Dr Mohan Rao (2011), Dr Ananthram (2012), Dr Matthias W Hoffmann (2013), Dr S Vittal (2014) and Dr Anthony Pais (2015).

Dr Kiran Belani on the contents cover page July's Minneapolis St. Paul Magazine

E-mail Print PDF

TOP Doctors 2015: Emerging Medicine

Six Twin Cities Top Docs who are on the forefront of innovation in medicine weigh in on the medical breakthroughs—from healthier kids to better sleep—we can expect in the next 20 years.


Kiran K. Belani says it’s not uncommon to have a set career path in her home country, India. For Belani, that path was medicine (there are 10 doctors in her family). She entered St. John’s Medical College in Bangalore at 16. Her specialty is pediatric infectious disease. She is board-certified in pediatrics and pediatric infectious disease and has a diploma in travel/tropical medicine and hygiene. She is on staff at Children’s Hospitals and Clinics of Minnesota.

In 1985, you began caring for the first child in Minnesota to be diagnosed with HIV. You cared for her and other children like her. What was that experience like?

In the early days, children would get hospitalized frequently. It was very hard on the nurses—after doing so much, the children would still die. We didn’t have the drugs. After 1996, we had more drugs. Now we have 30-some drugs, and now it’s almost boring: You see the patients in clinic, you check with their life issues, not disease issues. It’s a total 180-degree turnaround. I wish more diseases would go from life-threatening to a chronic, stable course.

What has been the biggest change in pediatric infectious disease?

The last 30 years in America, we would see so many meningitis cases each week—six or seven in a month. Then they started developing vaccines. It’s two to three cases per year now. In the past, we’d have to tell parents their children would have brain or neurological deficits. We don’t have to say that as often anymore.

In infectious disease, we tend to see more refugees than other fields. We see people from South Asia, Burma (Myanmar), Africa. We see most often tuberculosis, parasitic disease like malaria or gastrointestinal parasites.

Parents are happy they can get help for their children. In their countries, TB can be a death sentence. Coming from another country, I’m sensitive to cultural issues. We have to get to know each community’s different sensitivities. We have interpreters, social workers. It’s not isolating anymore to take care of someone from another country. It’s a daily routine.

What are your thoughts on vaccinations?

Vaccinations are the greatest thing that happened in the last 70 years. These diseases are not simple diseases. They can cause harm and last the lifetime of the child. The problem is that people aren’t seeing the diseases around them. But they are just a plane ride away. There’s measles, whooping cough, diphtheria in other countries. When you don’t see a bad thing, you don’t think about it. You get complacent. I try to give patients the facts. I give them the data. Look at it then, look at it now.

What are the lessons of Ebola?

We need a little more planning ahead—I think this is happening. We have so many treatments and resources, but we don’t have medical literacy—understanding how Ebola is spread. When there is panic and fear, there is not enough communication about the pathology to the people suffering. The more complicated medicine gets, the more time we have to spend educating families and parents.

What ongoing research or projects in your field excite you today?

We are seeing more new drugs for tuberculosis. The drugs in HIV are a tremendous help. I have a picture of a patient with a dinner plate full of the 25 medications she took for HIV. Now patients like her come to the office for a single pill with three drugs in them. It’s very exciting.

Genetics is very exciting—where you tailor the medicine to the patient’s specific genetic needs. Suppose you have a problem with one medication. In the future, we’ll be able to tell we can’t use it. It’s customizing.

What innovations are on the horizon?

Getting to know the body’s natural flora is very trendy right now. There is research into bacteria living in us and their role. How are they helping us? How are they not helping us? That understanding will help chronic disease.

What would you like to see accomplished in the next 20 years?

Health for the rest of the world. I travel to India a lot. There are still tons and tons of people who don’t have vaccinations, antibiotics. They die of simple things. Gaps between advances here and gaps in other countries like India are big, but it is improving.

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »

Page 1 of 83